企業プロフィール
Dr. Reddy's Laboratories Ltd 株価・ニュース・カタリスト
- ティッカー:
- RDY
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- India and listed in the U
株価パフォーマンス
12.11 USD (-1.30%)
終値
最終更新: 2026年8月17日
10.8B USD
時価総額
株価変動の要因
As of Aug 17, 2026, RDY closed down 1.30% at $12.11. No new same-company headline was identified in the current news window.
企業概要
事業概要
Dr. Reddy’s Laboratories is a global pharmaceutical company with a broad mix of generics, biosimilars, and specialty products. Its business is defined by scale, manufacturing, and a diversified international footprint.
所在地とセクター分類
Headquartered in India and listed in the U.S. as an ADR, Dr. Reddy’s has a large global presence across emerging and developed markets. It sits in generics and diversified pharmaceuticals rather than biotech.
ビジネスモデルの特徴
The company generates value through product volume, manufacturing execution, and portfolio breadth across regulated and emerging markets. Investors watch pricing pressure, product launches, and margin discipline.
バイオ業界での位置付け
Dr. Reddy’s is not a biotech company, but it is relevant to the broader pharma landscape because it participates in biosimilars and global drug supply. Its stock is driven by manufacturing and commercial execution, not clinical catalysts.
今後のカタリスト
- Dr. Reddy’s catalysts are US generics execution, biosimilar filings, and continued margin discipline. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。